Barclays’s Chimerix, Inc. CMRX Stock Holding History

Barclays’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-85,000	Closed	-$334K	–	6834
2016 Q2	$334K	Hold	85,000	–	–	﹤0.01%	3544
2016 Q1	$425K	Sell	85,000 -414,000	-83%	-$2.7M	﹤0.01%	3279
2015 Q4	$3.99M	Buy	+499,000	New	+$18M	﹤0.01%	1480
2015 Q2	–	Sell	-218,600	Closed	-$8.09M	–	7246
2015 Q1	$8.09M	Buy	+218,600	New	+$8.68M	0.01%	1216

Other funds holding CMRX

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Barclays's CMRX Position: Q2 2025 in Review

Barclays sold out of Chimerix, Inc. (CMRX) in Q2 2025, closing a stake of 88,435 shares — an estimated $753K sold.

Barclays first reported a position in CMRX in Q2 2013 and held it in 48 quarters. The position peaked at $1.26M in Q4 2022. 1 fund tracked by Wall St. Rank holds CMRX as of Q2 2025.

Barclays reported no remaining Chimerix, Inc. position as of Q2 2025 after selling out during the quarter.
Barclays sold 88,435 Chimerix, Inc. shares in Q2 2025, an estimated $753K.
Barclays first reported a position in Chimerix, Inc. in Q2 2013 and held it in 48 quarters.
Barclays's Chimerix, Inc. position peaked at $1.26M in Q4 2022.
1 fund tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2025.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.